2025. August 28., Thursday
Szegedi Tudományegyetem Szent-Györgyi Albert Orvostudományi Kar

University of Szeged
Albert Szent-Györgyi Medical School
 
Foreign Students' Secretariat




Your Education. Our Mission.

Clinical Module

Fourth and fifth year students study according to the curriculum 9001AK_N_2013 of University of Szeged, Albert Szent-Györgyi Medical School.

In order to obtain the Doctor of Medicine diploma, students need to acquire a minimum of 360 credits (by fulfilling the study and examination requirements of the subjects listed in the suggested study plan). In the final year, students, furthermore, have to complete the Final (State Board) Examination which consists of writing and defending a thesis, passing a complex written test and an oral patient examination (theoretical and practical part).


The order of taking the courses is set in the suggested study plan which is designed for completing medical studies within 12 semesters (6 years).
It is highly recommended to take the courses according to the suggested study plan.







Latest news

dean_s_welcome

It is with great pleasure and respect that I welcome you, the youngest students of the Albert Szent-Györgyi Medical School, who are about to start your higher education studies at our university!

511306818_10223012187572997_8372254519472257270_n

Calling All Alumni!

SZTE-MSD_egyuttmukodesi_megallapodas_alairas_2

The University of Szeged and MSD have established a joint Pharmaceutical Industry Partnership Department, marking a new chapter in their collaboration. This initiative builds on a long-standing partnership – further strengthened in 2023 through clinical trial cooperation – and seeks to foster innovation in research, education, and pharmaceutical development. The agreement was officially signed in Szeged by Prof. Dr. László Rovó, Rector of the University of Szeged; Prof. Dr. Ildikó Csóka, Director-General for Strategic Planning; Prof. Dr. Zsolt Szakonyi, Dean of the Faculty of Pharmacy; Sean R. Smith, Managing Director of MSD Pharma Hungary Kft.; and Dr. Szabolcs Barótfi, Director of Clinical Research at MSD Hungary.